CL
54
4
GME
75
-2
DUK
57
3
D
43
-2
HP
30
5
ETR
71
-4
VIX
30
-2
WMB
56
-3
QCOM
65
3
BMY
50
5
EXPE
70
-2
VTR
47
3
MKC
65
2
WDC
64
-4
DNB
40
2
THC
49
-7
SLB
44
6
WY
45
3
EIX
40
3
IPG
43
5
CL
54
4
GME
75
-2
DUK
57
3
D
43
-2
HP
30
5
ETR
71
-4
VIX
30
-2
WMB
56
-3
QCOM
65
3
BMY
50
5
EXPE
70
-2
VTR
47
3
MKC
65
2
WDC
64
-4
DNB
40
2
THC
49
-7
SLB
44
6
WY
45
3
EIX
40
3
IPG
43
5
Financhill
Back

Immunovant Stock Predictions

7 Stocks to Buy and Hold Forever

The result is a select group of high-quality blue-chip stocks.
Sell
24

IMVT
Immunovant

Last Price:
$16.14
Seasonality Move:
19.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Sleep well at night with 7 stellar stocks to buy and hold forever

Get the complete list FREE for a limited time.

Immunovant Stock Forecast

  • Over the next 52 weeks, Immunovant has on average historically risen by 44.5% based on the past 5 years of stock performance.
  • Immunovant has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Immunovant Stock Undervalued?
    The current Immunovant [IMVT] share price is $16.74. The Score for IMVT is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • IMVT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Immunovant Stock Go Up Next Year?

  • Over the next 52 weeks, Immunovant has on average historically risen by 44.5% based on the past 5 years of stock performance.

Immunovant Stock Rating

Sell
24
Immunovant (IMVT) is a Sell

Is Immunovant overpriced?

  • Immunovant has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Immunovant Stock Price History

Is IMVT stock going to rise?

  • The current trend is moderately bullish and IMVT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immunovant.com

52-Week Data

52-Week High:
34.47
52-Week Low:
12.72

Prediction Charts

Market Cap:
2.9B
Price in USD:
16.74
Volume:
1.5M
Beta:
0.73

Technical Analysis

SMA50:
14.97
SMA100:
17.77
SMA200:
23.21
52-Wk Change:
-34.12%

Stock Predictions

  • Is Immunovant stock public?
    Yes, Immunovant is a publicly traded company.
  • What is the Immunovant stock quote today?
    The Immunovant stock price is 16.74 USD today.
  • How to buy Immunovant stock online?
    You can buy Immunovant shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-21 14.74 14.41 14.94 14.34
May-22 14.48 14.56 14.67 14.15
May-23 14.19 14.46 14.48 14.11
May-27 14.79 14.29 14.88 14.04
May-28 14.30 14.10 14.92 13.79
May-29 14.75 14.89 15.22 14.09
May-30 14.77 14.85 15.02 14.29
Jun-2 14.83 15.41 15.49 14.58
Jun-3 15.46 15.44 15.84 15.21
Jun-4 15.58 15.34 15.66 15.30
Jun-5 15.35 16.02 16.16 15.02
Jun-6 16.35 16.77 17.10 16.26
Jun-9 17.08 16.29 17.15 15.95
Jun-10 16.38 16.74 16.96 16.30

Immunovant Earnings

Immunovant Earnings Report: Per Share Immunovant Earnings Q1 Q2 Q3 and Q4 last year and next year.

Immunovant Forecast Revenue Growth

Immunovant Stock Analysis: Historical quarterly revenues per share for Immunovant and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.07 per share, a decrease this year of $1.13 per share, and an increase next year of $0.02 per share.

* Immunovant stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.